News
Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...
The maker of Ozempic and Wegovy found fake 1-milligram injections were being distributed through unauthorized sellers.
It's not clear which children would benefit, when to start the drugs and, once started, whether children would have to stay ...
The maker of Ozempic and the weight loss drug Wegovy told the FDA on April 3 that counterfeit 1-milligram injections were ...
People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...
The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...
Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access ...
Shares of weight-loss drugmakers Novo Nordisk A/S and Eli Lilly and Co. got a nice lift Monday, after a potential competitor decided to cancel development of its GLP-1 obesity drug. “We continue ...
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...
The Canadian Press on MSN4h
New obesity guidelines for kids address when medication is an optionTORONTO — A new guideline for treating obesity in children and adolescents says medication can be helpful, but that health providers should prioritize addressing nutrition, exercise and psychological ...
U.S. President Donald Trump directed his health department on Tuesday to work with Congress on revamping a law that allows ...
The drug manufacturer will no longer study and test danuglipron after a participant in a clinical trial was injured.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results